Epistem’s facilities include the first Bruker In Vivo Xtreme Imaging System in the UK. The high resolution imaging system combines four modalities; luminescence, fluorescence, radioisotope imaging and X-ray. This sophisticated system enables high throughput, flexible imaging with rapid multimodal acquisition and is specifically designed for complex preclinical investigations. Combined with established expertise in imaging, this state-of-the-art system is a powerful addition to Epistem’s in vivo preclinical models. 

Capabilities of Epistem’s Imaging Service: 

  • Non-invasive longitudinal tumour xenograft imaging
  • Stem cell tracking
  • Imaging of inflammation
  • Tracking and validating single or multimodal nanoparticles 
  • Imaging and validating new probes and biomarkers
  • Non-invasively image changes in signalling cascades
  • Discover how genetics, small molecules and therapeutics affect biochemical pathways
  • Quantify changes in bone and soft tissue phenotype
  • High throughput pharmacodynamic studies

Epistem's imaging service can be used to support in-house models including:

Oncology
Inflammation

The Bruker In Vivo Xtreme Imaging System

The Bruker In Vivo Xtreme Imaging System

Want to ask a question about

Preclinical Imaging?

Need more information?

Contact us via

info@epistem.co.uk

+44 (0)161 850 7600

webform